Back to Search Start Over

[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].

Authors :
Wada A
Doki N
Otsuka Y
Adachi H
Konuma R
Kishida Y
Konishi T
Yamada Y
Nagata A
Nagata R
Marumo A
Noguchi Y
Mukae J
Toya T
Igarashi A
Najima Y
Kobayashi T
Harada H
Harada Y
Sakamaki H
Ohashi K
Source :
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2022; Vol. 63 (2), pp. 104-107.
Publication Year :
2022

Abstract

Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.

Details

Language :
Japanese
ISSN :
0485-1439
Volume :
63
Issue :
2
Database :
MEDLINE
Journal :
[Rinsho ketsueki] The Japanese journal of clinical hematology
Publication Type :
Academic Journal
Accession number :
35264498
Full Text :
https://doi.org/10.11406/rinketsu.63.104